Delivery Order SPE2DB22D2211-SPE2DB24FNDN3
Award Date
4/8/24
Potential Completion Date
4/29/24
Potential Value
$9.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $8,996.48, is for the supply of HYPERRAB 300 UNIT/ML VIAL 3ML, a medical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $9,391.75 Delivery Order is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $7,513.40 award is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a specialty pharmaceutical product. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a Firm Fixed Price delivery order contract valued at $1,116.57 by the Defense Logistics Agency (DLA) to provide HYPERRAB 300 UNIT/ML VIALML pharmaceuticals. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
The Defense Logistics Agency (DLA) awarded a $9,192.90 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,561,948 units of a 5 mL HYPERRAB 300 unit/mL vial. This contract has an ultimate completion date of September 18, 2023 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical...
This federal contract award is a $1,039.53 Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of HYPERRAB 300 UNIT/ML VIALML, a medical product, with a completion date of February 25, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,490.29 firm fixed-price delivery order is for the supply of HYPERRAB 300 UNIT/ML VIAL 3ML medical products. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML. The delivery order is valued at $3,756.72 and has a firm fixed-price pricing structure. The ultimate completion date for this contract is August 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML medical products. The $11,031.48 firm fixed price contract has a completion date of March 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,744.80 firm fixed-price delivery order is for the medical product "HYPERRAB 300 UNIT/ML VIAL 5ML" and has an ultimate completion date of April 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...